Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 10 min ago

GSK and Theravance Announce Positive Data From Two Studies Evaluating the Efficacy and Safety of Incruse(TM) Ellipta(R) When Added to Relvar(R)/Breo(R) Ellipta(R) in Patients With COPD

Wed, 06/11/2014 - 12:41
LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA--(Healthcare Sales & Marketing Network) - GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive results from two phase III studies, which showed that patie...
Biopharmaceuticals
Theravance, GlaxoSmithKline, COPD , Incruse Ellipta, umeclidinium

Navidea Biopharmaceuticals’ Lymphoseek(R) (technetium Tc 99m tilmanocept) Injection Demonstrates Preferential Accumulation in Tumor-Positive Sentinel Lymph Nodes in Post-Hoc Analysis

Wed, 06/11/2014 - 12:23
Ability of receptor-targeted Lymphoseek to accurately target appropriate lymph nodes may lessen patient morbidity from extensive oral cavity surgery DUBLIN, Ohio--(Healthcare Sales & Marketing Network)--Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), ...
Biopharmaceuticals, Oncology
Navidea Biopharmaceuticals, Lymphoseek, radiopharmaceutical

Ivera Medical Announces Extension of Novation Agreement

Wed, 06/11/2014 - 12:12
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Ivera Medical Corporation, a certified minority-owned business, announced an extension of its agreement with Novation for the Curos® family of products. The agreement, which originally commenced o...
Devices, Group Purchasing
Ivera Medical, Novation , Curos Port Protectors, Curos Strips, Curos Tips

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong